22:
205:(HGF) and its receptor, MET, which are expressed in normal central nervous system function. It aims to regenerate lost connections in the brain, protect brain cells from further damage, and prevent additional neuronal deterioration. ATH-1017 is currently being tested in two clinical studies: ACT-AD and LIFT-AD.
183:
Leen Kawas served as the company's first
President and CEO, but resigned in October 2021, after an independent special committee found she "altered images in scientific papers she authored." On October 21, 2021, Mark Litton, Ph.D., M.B.A. became Chief Executive Officer.
192:
The company has received financial support from venture capitalist groups and angel investors through four rounds of funding to date. Athira Pharma was known as M3 Biotechnology until it underwent a name change on April 11, 2019.
375:
201:
The company's lead asset, ATH-1017, is in human trials of
Alzheimer's disease as of 2021. ATH-1017 is a small molecule therapeutic specifically designed to enhance the activity of
622:
642:
157:
is a late clinical stage
American biopharmaceutical company developing small molecules to restore neuronal health and stop the neurodegeneration brought on by diseases such as
346:"Athira Pharma Announces Leadership Changes; Mark Litton, Ph.D., M.B.A. Named President and Chief Executive Officer; Rachel Lenington, M.B.A. Named Chief Operating Officer"
637:
627:
345:
383:
430:
247:
173:
500:
222:
632:
320:
475:
38:
60:
31:
545:"M3 Biotechnology Launches Clinical Trials for Alzheimer's Disease Drug Focused on Restoring Lost Connections in the Brain"
566:"A Randomized, Placebo-Controlled, Translational Study of ATH-1017 in Subjects With Mild to Moderate Alzheimer's Disease"
449:
202:
162:
158:
573:
248:"ADDF Funding Advances M3 Biotechnology Toward Clinical Trials | Alzheimer's Drug Discovery Foundation"
172:. Funding that supports the company is from both public and private investment groups including the
165:. The company's lead candidate, ATH-1017, is in human studies for Alzheimer's disease as of 2021.
376:"Ex-Athira Pharma CEO Leen Kawas resigns and leaves board after image manipulation investigation"
42:
544:
586:
461:
37:
It may require cleanup to comply with
Knowledge (XXG)'s content policies, particularly
616:
90:
80:
405:
271:
565:
223:"Athira Pharma Reports Second Quarter 2021 Financial Results and Business Update"
176:, Dolby Family Ventures, the State of Washington's Life Sciences Discovery Fund,
296:
177:
406:"M3 Biotechnology Company Profile: Valuation & Investors | PitchBook"
520:
501:"Dosing Starts in Phase 2/3 Trial of Athira's ATH-1017 for Alzheimer's"
169:
117:
86:
272:"First Trial of Alzheimer's Drug Underway | Science and Enterprise"
476:"Alzheimer's-focused M3 Biotechnology rebrands as Athira Pharma"
431:"M3 Biotechnology Announces Name Change to Athira Pharma, Inc"
15:
605:
168:
The company was founded in 2011 and is headquartered in
141:
321:"Entrepreneurship has grown on M3 Biotechnology's CEO"
30:
A major contributor to this article appears to have a
136:
128:
112:
104:
96:
78:
297:"Individual Grants | Life Sciences Discovery Fund"
8:
623:Biotechnology companies of the United States
180:, WRF Capital, and other private investors.
73:
643:Biotechnology companies established in 2011
499:Delgado, Diana Campelo (12 October 2020).
72:
638:2011 establishments in Washington (state)
61:Learn how and when to remove this message
214:
628:American companies established in 2011
582:
571:
457:
447:
350:Athira Pharma - Company Press Releases
174:Alzheimer's Drug Discovery Foundation
7:
369:
367:
374:Soper, Taylor (October 21, 2021).
14:
41:. Please discuss further on the
20:
276:sciencebusiness.technewslit.com
100:Biotechnology, Pharmaceuticals
1:
564:Athira Pharma (2021-08-24).
659:
633:Companies based in Seattle
203:Hepatocyte Growth Factor
581:Cite journal requires
39:neutral point of view
429:Inc, Athira Pharma.
252:www.alzdiscovery.org
386:on October 21, 2021
163:Parkinson's disease
159:Alzheimer's disease
75:
460:has generic name (
450:cite press release
435:www.prnewswire.com
352:. October 21, 2021
74:Athira Pharma Inc.
325:The Seattle Times
278:. 17 October 2017
152:
151:
71:
70:
63:
34:with its subject.
650:
609:
608:
606:Official website
591:
590:
584:
579:
577:
569:
561:
555:
554:
552:
551:
541:
535:
534:
532:
531:
517:
511:
510:
508:
507:
496:
490:
489:
487:
486:
472:
466:
465:
459:
455:
453:
445:
443:
442:
426:
420:
419:
417:
416:
402:
396:
395:
393:
391:
382:. Archived from
371:
362:
361:
359:
357:
342:
336:
335:
333:
332:
317:
311:
310:
308:
307:
293:
287:
286:
284:
283:
268:
262:
261:
259:
258:
244:
238:
237:
235:
234:
219:
148:
145:
143:
76:
66:
59:
55:
52:
46:
32:close connection
24:
23:
16:
658:
657:
653:
652:
651:
649:
648:
647:
613:
612:
604:
603:
600:
595:
594:
580:
570:
563:
562:
558:
549:
547:
543:
542:
538:
529:
527:
519:
518:
514:
505:
503:
498:
497:
493:
484:
482:
474:
473:
469:
456:
446:
440:
438:
437:(Press release)
428:
427:
423:
414:
412:
404:
403:
399:
389:
387:
373:
372:
365:
355:
353:
344:
343:
339:
330:
328:
319:
318:
314:
305:
303:
295:
294:
290:
281:
279:
270:
269:
265:
256:
254:
246:
245:
241:
232:
230:
221:
220:
216:
211:
199:
197:Core technology
190:
140:
124:
120:
83:
67:
56:
50:
47:
36:
25:
21:
12:
11:
5:
656:
654:
646:
645:
640:
635:
630:
625:
615:
614:
611:
610:
599:
598:External links
596:
593:
592:
583:|journal=
556:
536:
521:"Our Approach"
512:
491:
467:
421:
397:
363:
337:
312:
288:
263:
239:
213:
212:
210:
207:
198:
195:
189:
186:
150:
149:
138:
134:
133:
130:
126:
125:
122:
116:
114:
110:
109:
106:
102:
101:
98:
94:
93:
84:
79:
69:
68:
28:
26:
19:
13:
10:
9:
6:
4:
3:
2:
655:
644:
641:
639:
636:
634:
631:
629:
626:
624:
621:
620:
618:
607:
602:
601:
597:
588:
575:
567:
560:
557:
546:
540:
537:
526:
525:Athira Pharma
522:
516:
513:
502:
495:
492:
481:
480:FierceBiotech
477:
471:
468:
463:
451:
436:
432:
425:
422:
411:
410:pitchbook.com
407:
401:
398:
385:
381:
377:
370:
368:
364:
351:
347:
341:
338:
326:
322:
316:
313:
302:
301:www.lsdfa.org
298:
292:
289:
277:
273:
267:
264:
253:
249:
243:
240:
228:
227:Athira Pharma
224:
218:
215:
208:
206:
204:
196:
194:
187:
185:
181:
179:
175:
171:
166:
164:
160:
156:
155:Athira Pharma
147:
139:
135:
131:
127:
123:United States
119:
115:
111:
107:
103:
99:
95:
92:
88:
85:
82:
77:
65:
62:
54:
44:
40:
35:
33:
27:
18:
17:
574:cite journal
559:
548:. Retrieved
539:
528:. Retrieved
524:
515:
504:. Retrieved
494:
483:. Retrieved
479:
470:
439:. Retrieved
434:
424:
413:. Retrieved
409:
400:
388:. Retrieved
384:the original
379:
354:. Retrieved
349:
340:
329:. Retrieved
327:. 2017-04-30
324:
315:
304:. Retrieved
300:
291:
280:. Retrieved
275:
266:
255:. Retrieved
251:
242:
231:. Retrieved
229:. 2021-08-16
226:
217:
200:
191:
182:
167:
154:
153:
113:Headquarters
57:
48:
29:
458:|last=
617:Categories
550:2018-10-15
530:2021-10-20
506:2021-08-30
485:2021-10-20
441:2019-04-15
415:2018-10-15
331:2018-07-31
306:2018-07-31
282:2018-10-15
257:2018-10-15
233:2021-10-20
209:References
178:The W Fund
51:March 2019
81:Traded as
43:talk page
390:July 10,
380:GeekWire
356:July 10,
132:ATH-1017
129:Products
97:Industry
188:History
170:Seattle
144:.athira
137:Website
118:Seattle
105:Founded
89::
87:Nasdaq
587:help
462:help
392:2022
358:2022
161:and
146:.com
108:2011
91:ATHA
142:www
619::
578::
576:}}
572:{{
523:.
478:.
454::
452:}}
448:{{
433:.
408:.
378:.
366:^
348:.
323:.
299:.
274:.
250:.
225:.
121:,
589:)
585:(
568:.
553:.
533:.
509:.
488:.
464:)
444:.
418:.
394:.
360:.
334:.
309:.
285:.
260:.
236:.
64:)
58:(
53:)
49:(
45:.
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.